| Literature DB >> 31583294 |
Hiroyuki Matsuzaki1,2, Soichiro Ishihara1, Kazushige Kawai1, Koji Murono1, Kensuke Otani1, Koji Yasuda1, Takeshi Nishikawa1, Toshiaki Tanaka1, Tomomichi Kiyomatsu1, Keisuke Hata1, Hiroaki Nozawa1, Toshiaki Watanabe1.
Abstract
OBJECTIVES: To clarify the surgical outcomes and risk factors for anastomotic leakage (AL) following laparoscopic anterior resection (Lap-AR) for the treatment of rectal cancer. <br> METHODS: We retrospectively reviewed the records of 175 consecutive primary rectal cancer patients who had undergone Lap-AR at our institution between April 2012 and November 2015. Patient, tumor, and surgical variables were analyzed using univariate analyses. <br> RESULTS: Of 175 patients, 116 were men (66.3%). All four patients who had AL (2.3%) were men and current smokers with heavy smoking histories. In three of the AL cases, preoperative total colonoscopy was impossible owing to tumor obstruction, and the other case had concomitant obstructive colitis after oral bowel preparation. Univariate analysis identified tumor size, tumor obstruction, and smoking history as factors significantly associated with AL development. <br> CONCLUSIONS: Tumor size, tumor obstruction, and smoking history were risk factors for AL following Lap-AR for the treatment of primary rectal cancer.Entities:
Keywords: anastomotic leakage; laparoscopic surgery; rectal cancer; smoking; tumor obstruction
Year: 2018 PMID: 31583294 PMCID: PMC6768678 DOI: 10.23922/jarc.2016-012
Source DB: PubMed Journal: J Anus Rectum Colon ISSN: 2432-3853
Figure 1.Port placement.
Numbers in circles represent port diameter in millimeters.
Figure 2.Reinforcing serosal suture after anvil placement.
Figure 3.Intraoperative colonoscopy.
A) Normal anastomotic site without bleeding.
B) Bleeding from anastomotic site.
C) Hemostasis with an endoscopic clip.
D) Placement of multilumen transanal drain.
Figure 4.Placement of multilumen transanal drain.
A) High anastomosis.
B) Low anastomosis.
Patient and Tumor Backgrounds.
| N=175 | ||
| Age (years) | 63 (36-87) | |
| Body mass index (kg/m2) | 22.5 (15.8-32.4) | |
| Male gender | 116 (66.3%) | |
| ASA score | ||
| 1 | 78 (44.6%) | |
| 2 | 92 (52.6%) | |
| 3 | 5 ( 2.8%) | |
| Tumor location | ||
| Upper | 87 (49.7%) | |
| Middle | 61 (34.9%) | |
| Lower | 27 (15.4%) | |
| TNM stage | ||
| 0 | 3 ( 1.7%) | |
| I | 50 (28.6%) | |
| II | 48 (27.4%) | |
| III | 62 (35.4%) | |
| IV | 12 ( 6.9%) | |
| Tumor size (mm) | 32 (3-200) | |
| Preoperative chemoradiotherapy | 23 (13.1%) | |
*Values are expressed as median (range) or number (%).
ASA: American society of anesthesiologists
Surgical Results.
| N=175 | ||
| Operative time (min) * | 256 (128-605) | |
| Blood loss (ml) * | 10 (0-3350) | |
| Cartridges for rectal transection | ||
| 1 | 64 (36.6%) | |
| 2 | 80 (45.7%) | |
| ≥3 | 31 (17.7%) | |
| High tie of inferior mesenteric artery | 40 (22.9%) | |
| Lateral lymph node dissection | 7 ( 4.0%) | |
| Placement of pelvic drain | 160 (91.4%) | |
| Placement of transanal drain | 167 (95.4%) | |
| Diverting stoma | 35 (20.0%) | |
| Leak test positive | 3 ( 1.7%) | |
| Postoperative C-reactive protein (mg/dl) | 4.5 (0.0-20.8) | |
*Values are expressed as median (range) or number (%).
Complications.
| n | % | |
|---|---|---|
| Total | 33 | 18.9 |
| Superficial surgical site infection | 7 | 4.0 |
| Anastomotic leakage | 4 | 2.3 |
| Intraabdominal abscess | 1 | 0.6 |
| Port site hernia | 5 | 2.9 |
| Urinary retention | 5 | 2.9 |
| Ileus | 4 | 2.3 |
| Pulmonary | 2 | 1.1 |
| Anastomotic bleeding | 1 | 0.6 |
| Cerebral infarction | 1 | 0.6 |
| Anemia | 1 | 0.6 |
| Enterocolitis | 1 | 0.6 |
| Jaundice | 1 | 0.6 |
| Clavien-Dindo classification | ||
| Grade I | 4 | 2.3 |
| Grade II | 16 | 9.1 |
| Grade III | 11 | 6.3 |
| Grade IV | 2 | 1.1 |
Anastomotic Leakage Cases.
| Case number | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Sex | Man | Man | Man | Man |
| Age (years) | 75 | 59 | 64 | 48 |
| Body mass index (kg/m2) | 25.4 | 23.6 | 21.8 | 25.2 |
| Tumor location (anal verge, cm) | 14 | 12 | 7 | 8 |
| Preoperative colonoscopy findings | obstruction | obstruction | obstruction | obstructive colitis |
| Current smoking | yes | yes | yes | yes |
| Smoking index (Packs/year) | 60 | 40 | 44 | 30 |
| Laparotomy history | no | yes | no | no |
| Diabetes | yes | no | yes | no |
| Use of corticosteroid | no | no | no | no |
| Other comorbidity | COPD, HT | CKD, HT | HT | - |
| Preoperative albumin (g/dl) | 4.0 | 3.2 | 3.6 | 4.1 |
| Preoperative chemoradiotherapy | no | no | no | no |
| ASA score | 2 | 2 | 2 | 1 |
| Operative time (min) | 234 | 357 | 378 | 605 |
| Blood loss (ml) | 6 | 200 | 150 | 3350 |
| Inferior mesenteric artery (high tie/low tie) | low | low | low | low |
| Cartridges for rectal transection | 2 | 3 | 3 | 2 |
| Lateral lymph node dissection | no | no | no | yes |
| Diverting stoma | no | yes | no | no |
| Postoperative day of anastomotic leakage diagnosis (day) | 9 | 6 | 4 | 4 |
| Treatment of anastomotic leakage | conservative | re-operation | conservative | conservative |
| Duration of pelvic drainage (day) | 32 | 63 | 42 | 40 |
| Duration of transanal drainage (day) | 7 | 69 | 26 | 32 |
| Duration of hospital stay (day) | 42 | 71 | 55 | 42 |
| Tumor size (mm) | 48 | 52 | 200 | 65 |
| TNM stage | IIA | IIIB | IIIC | IVA |
| Tumor | 3 | 4a | 4a | 3 |
| Node | 0 | 1b | 2b | 2c |
| Metastasis | 0 | 0 | 0 | 1a |
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HT, hypertension
ASA: American society of anesthesiologists
Univariate Analysis of Risk Factors for Anastomotic Leakage.
| Variables | Leakage (+) | Leakage (-) | Univariate | |
|---|---|---|---|---|
| n=4 | n=171 | P value | ||
| Age (years) | 61 (48-75) | 63 (36-87) | 0.865 | |
| Body mass index (kg/m2) | 24.4 (21.8-25.4) | 22.4 (15.8-32.4) | 0.287 | |
| Preoperative albumin | 3.8 (3.2-4.0) | 4.0 (2.2-4.9) | 0.171 | |
| Tumor size (mm) | 58 (48-200) | 31 (3-100) | 0.024 | |
| Sex | Male | 4 (100%) | 0 ( 0%) | 0.300 |
| Tumor location | Lower | 0 ( 0%) | 27 (15.8%) | 0.637 |
| Middle | 2 ( 50%) | 59 (34.5%) | ||
| Upper | 2 ( 50%) | 85 (49.7%) | ||
| Tumor obstruction | Yes | 3 ( 75%) | 18 (10.5) | 0.005 |
| Current smoking | Yes | 4 (100%) | 39 (22.8%) | 0.003 |
| Smoking index (Packs/year) | 42 (30-60) | 7 (0-160) | 0.019 | |
| Laparotomy history | Yes | 1 ( 25%) | 47 (27.5%) | 1.000 |
| Diabetes | Yes | 2 ( 50%) | 34 (19.9%) | 0.188 |
| Use of corticosteroid | Yes | 0 ( 0%) | 2 ( 1.2%) | 1.000 |
| Preoperative chemoradiotherapy | Yes | 0 ( 0%) | 23 (13.5%) | 1.000 |
| ASA score | 1 | 1 ( 25%) | 77 (45.0%) | 0.667 |
| 2 | 3 ( 75%) | 89 (52.1%) | ||
| 3 | 0 ( 0%) | 5 ( 2.9%) | ||
| Cartridges for rectal transection | 1 | 0 ( 0%) | 64 (37.4%) | 0.180 |
| 2 | 2 ( 50%) | 78 (45.6%) | ||
| ≥3 | 2 ( 50%) | 29 (17.0%) | ||
| High tie of inferior mesenteric artery | Yes | 0 ( 0%) | 40 (23.4%) | 0.575 |
| Lateral lymph node dissection | Yes | 1 ( 25%) | 6 ( 3.5%) | 0.152 |
| Leak test | Positive | 0 ( 0%) | 3 (1.75%) | 1.000 |
| TNM stage | 0 | 0 ( 0%) | 3 ( 1.8%) | 0.328 |
| I | 0 ( 0%) | 50 (29.2%) | ||
| II | 1 ( 25%) | 47 (27.5%) | ||
| III | 2 ( 50%) | 60 (35.1%) | ||
| IV | 1 ( 25%) | 11 ( 6.4%) | ||
| Operative time | 367 (234-605) | 255 (128-602) | 0.049 | |
| Blood loss | 175 (6-3350) | 10 (0-500) | 0.033 | |
*Values are expressed as median (range) or number (%).
ASA: American society of anesthesiologists